167 related articles for article (PubMed ID: 35023131)
1. Developing Treatments for Alzheimer's and Related Disorders with Precision Medicine: A Vision.
Avramopoulos D; Kapogiannis D; Leoutsakos JM; Lyketsos CG; Mahairaki V; Nowrangi M; Oishi K; Oh ES; Rosenberg PB; Samus Q; Smith GS; Witwer K; Yasar S; Zandi PP
Adv Exp Med Biol; 2021; 1339():395-402. PubMed ID: 35023131
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers and Precision Medicine in Alzheimer's Disease.
Sagar R; Pathak P; Pandur B; Kim SJ; Li J; Mahairaki V
Adv Exp Med Biol; 2021; 1339():403-408. PubMed ID: 35023132
[TBL] [Abstract][Full Text] [Related]
3. Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.
Gauthier S; Ng KP; Pascoal TA; Zhang H; Rosa-Neto P
J Alzheimers Dis; 2018; 64(s1):S23-S31. PubMed ID: 29504543
[TBL] [Abstract][Full Text] [Related]
4. The Alzheimer Precision Medicine Initiative.
Hampel H; Vergallo A; Perry G; Lista S;
J Alzheimers Dis; 2019; 68(1):1-24. PubMed ID: 30814352
[TBL] [Abstract][Full Text] [Related]
5. The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease.
Behl T; Kaur I; Sehgal A; Singh S; Albarrati A; Albratty M; Najmi A; Meraya AM; Bungau S
Biomed Pharmacother; 2022 Sep; 153():113337. PubMed ID: 35780617
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy.
Latta CH; Brothers HM; Wilcock DM
Neuroscience; 2015 Aug; 302():103-11. PubMed ID: 25286385
[TBL] [Abstract][Full Text] [Related]
7. Evolution of genetic testing supports precision medicine for caring Alzheimer's disease patients.
Bruni AC; Bernardi L; Maletta R
Curr Opin Pharmacol; 2021 Oct; 60():275-280. PubMed ID: 34487952
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment.
De Matteis L; Martín-Rapún R; de la Fuente JM
Curr Med Chem; 2018; 25(35):4602-4615. PubMed ID: 29022501
[TBL] [Abstract][Full Text] [Related]
9. A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.
O'Bryant SE; Zhang F; Johnson LA; Hall J; Edwards M; Grammas P; Oh E; Lyketsos CG; Rissman RA
J Alzheimers Dis; 2018; 66(1):97-104. PubMed ID: 30198872
[TBL] [Abstract][Full Text] [Related]
10. Integrating Omic Technologies in Alzheimer's Disease.
Avramouli A; Vlamos PM
Adv Exp Med Biol; 2017; 987():177-184. PubMed ID: 28971457
[TBL] [Abstract][Full Text] [Related]
11. A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.
Hampel H; O'Bryant SE; Durrleman S; Younesi E; Rojkova K; Escott-Price V; Corvol JC; Broich K; Dubois B; Lista S;
Climacteric; 2017 Apr; 20(2):107-118. PubMed ID: 28286989
[TBL] [Abstract][Full Text] [Related]
12. Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach.
Schelke MW; Hackett K; Chen JL; Shih C; Shum J; Montgomery ME; Chiang GC; Berkowitz C; Seifan A; Krikorian R; Isaacson RS
Ann N Y Acad Sci; 2016 Mar; 1367(1):50-6. PubMed ID: 27116241
[TBL] [Abstract][Full Text] [Related]
13. A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
Badhwar A; McFall GP; Sapkota S; Black SE; Chertkow H; Duchesne S; Masellis M; Li L; Dixon RA; Bellec P
Brain; 2020 May; 143(5):1315-1331. PubMed ID: 31891371
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of Alzheimer's disease: consequence for drug trials?
Devi G; Scheltens P
Alzheimers Res Ther; 2018 Dec; 10(1):122. PubMed ID: 30567585
[TBL] [Abstract][Full Text] [Related]
15. Precision pharmacology for Alzheimer's disease.
Hampel H; Vergallo A; Aguilar LF; Benda N; Broich K; Cuello AC; Cummings J; Dubois B; Federoff HJ; Fiandaca M; Genthon R; Haberkamp M; Karran E; Mapstone M; Perry G; Schneider LS; Welikovitch LA; Woodcock J; Baldacci F; Lista S;
Pharmacol Res; 2018 Apr; 130():331-365. PubMed ID: 29458203
[TBL] [Abstract][Full Text] [Related]
16. Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification.
Hampel H; Vergallo A; Giorgi FS; Kim SH; Depypere H; Graziani M; Saidi A; Nisticò R; Lista S;
Front Neuroendocrinol; 2018 Jul; 50():31-51. PubMed ID: 29902481
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease.
Gong CX; Liu F; Iqbal K
J Alzheimers Dis; 2018; 64(s1):S107-S117. PubMed ID: 29562523
[TBL] [Abstract][Full Text] [Related]
18. Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.
Berkowitz CL; Mosconi L; Rahman A; Scheyer O; Hristov H; Isaacson RS
J Prev Alzheimers Dis; 2018; 5(4):245-252. PubMed ID: 30298183
[TBL] [Abstract][Full Text] [Related]
19. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.
Hampel H; Caraci F; Cuello AC; Caruso G; Nisticò R; Corbo M; Baldacci F; Toschi N; Garaci F; Chiesa PA; Verdooner SR; Akman-Anderson L; Hernández F; Ávila J; Emanuele E; Valenzuela PL; Lucía A; Watling M; Imbimbo BP; Vergallo A; Lista S
Front Immunol; 2020; 11():456. PubMed ID: 32296418
[TBL] [Abstract][Full Text] [Related]
20. Facing multimorbidity in the precision medicine era.
Onder G; Bernabei R; Vetrano DL; Palmer K; Marengoni A
Mech Ageing Dev; 2020 Sep; 190():111287. PubMed ID: 32562614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
